BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 126 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,533,000 | +61.3% | 3,401,744 | +12.4% | 0.00% | +33.3% |
| Q3 2016 | $13,352,000 | +64.9% | 3,027,595 | +6.2% | 0.00% | +50.0% |
| Q2 2016 | $8,095,000 | +2.1% | 2,850,238 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $7,926,000 | -72.5% | 2,800,786 | +0.4% | 0.00% | -71.4% |
| Q4 2015 | $28,789,000 | -13.3% | 2,789,584 | -4.2% | 0.01% | -22.2% |
| Q3 2015 | $33,194,000 | -21.3% | 2,911,728 | +3.1% | 0.01% | -10.0% |
| Q2 2015 | $42,158,000 | +63.2% | 2,823,718 | -1.3% | 0.01% | +66.7% |
| Q1 2015 | $25,834,000 | -24.2% | 2,860,900 | +2.0% | 0.01% | -25.0% |
| Q4 2014 | $34,103,000 | +36.8% | 2,804,541 | +10.1% | 0.01% | +14.3% |
| Q3 2014 | $24,921,000 | -23.6% | 2,548,170 | -0.4% | 0.01% | -22.2% |
| Q2 2014 | $32,616,000 | +243.3% | 2,558,112 | +184.8% | 0.01% | +200.0% |
| Q1 2014 | $9,502,000 | +49.8% | 898,132 | +7.6% | 0.00% | +50.0% |
| Q4 2013 | $6,344,000 | +487.4% | 834,789 | +462.8% | 0.00% | – |
| Q3 2013 | $1,080,000 | +462.5% | 148,335 | +19.6% | 0.00% | – |
| Q2 2013 | $192,000 | – | 123,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |